Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Dutkowski R.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii11-ii24. doi: 10.1093/jac/dkq012. Review.

2.

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.

Reddy D.

J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii35-ii40. doi: 10.1093/jac/dkq014. Review.

3.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

4.

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.

Matsuzaki Y, Mizuta K, Aoki Y, Suto A, Abiko C, Sanjoh K, Sugawara K, Takashita E, Itagaki T, Katsushima Y, Ujike M, Obuchi M, Odagiri T, Tashiro M.

Virol J. 2010 Mar 5;7:53. doi: 10.1186/1743-422X-7-53.

5.

Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.

Dharan NJ, Beekmann SE, Fiore A, Finelli L, Uyeki TM, Polgreen PM, Fry AM.

Antiviral Res. 2010 Nov;88(2):182-6. doi: 10.1016/j.antiviral.2010.08.010. Epub 2010 Aug 23.

PMID:
20739002
6.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM; Oseltamivir-Resistance Working Group.

JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.

PMID:
19255110
7.

Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Iwakuni O, Egashira K, Yamaji K, Kashiwagi S.

J Infect Chemother. 2012 Apr;18(2):180-6. doi: 10.1007/s10156-011-0314-2. Epub 2011 Dec 23.

PMID:
22193710
8.

Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.

Zaraket H, Saito R, Wakim R, Tabet C, Medlej F, Reda M, Baranovich T, Suzuki Y, Dapat C, Caperig-Dapat I, Dbaibo GS, Suzuki H.

J Med Virol. 2010 Jul;82(7):1224-8. doi: 10.1002/jmv.21795.

PMID:
20513088
9.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Renaud C, Kuypers J, Englund JA.

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. Review.

PMID:
21684202
10.

Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.

Hoang Vu MP, Nguyen CT, Nguyen le KH, Nguyen TK, Le QM.

Western Pac Surveill Response J. 2013 Jun 26;4(2):25-9. doi: 10.5365/WPSAR.2013.4.1.010. eCollection 2013 Apr-Jun.

11.

Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.

Dapat C, Saito R, Kyaw Y, Myint YY, Oo HN, Oo KY, Naito M, Hasegawa G, Dapat IC, Suzuki H.

Influenza Other Respir Viruses. 2013 Sep;7(5):766-71. doi: 10.1111/irv.12030. Epub 2012 Nov 5.

12.

Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.

Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, Saito K, Saito R, Suzuki H.

Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.

PMID:
23791870
13.

The epidemiology and spread of drug resistant human influenza viruses.

Hurt AC.

Curr Opin Virol. 2014 Oct;8:22-9. doi: 10.1016/j.coviro.2014.04.009. Epub 2014 May 24. Review.

PMID:
24866471
14.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
15.

Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.

Zaraket H, Dapat C, Ghanem S, Ali Z, Lteif M, Kondo H, Dapat IC, Saito K, Kayali G, Suzuki H, Dbaibo G, Saito R.

Intervirology. 2014;57(6):344-52. doi: 10.1159/000365758. Epub 2014 Oct 3.

16.

Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.

Yang JR, Huang YP, Chang FY, Hsu LC, Huang HY, Pan YT, Lin YC, Wu HS, Liu MT.

J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.

PMID:
23280715
17.

Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.

Cho HG, Choi JH, Lee HK, Mun SK, Lee JB, Jho EH, Kang C, Lim YH.

Arch Virol. 2013 Nov;158(11):2365-70. doi: 10.1007/s00705-013-1734-3. Epub 2013 May 21.

PMID:
23690054
18.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
19.

Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.

Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, Caperig-Dapat I, Suzuki H.

J Clin Microbiol. 2010 Apr;48(4):1085-92. doi: 10.1128/JCM.01532-09. Epub 2010 Feb 3.

20.

Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.

Lackenby A, Elliot AJ, Powers C, Andrews N, Ellis J, Bermingham A, Thompson C, Galiano M, Large S, Durnall H, Fleming D, Smith G, Zambon M.

J Antimicrob Chemother. 2013 Oct;68(10):2324-31. doi: 10.1093/jac/dkt203. Epub 2013 Jun 12.

PMID:
23759670

Supplemental Content

Support Center